Rua Bioscience

Rua is a New Zealand cannabis pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in the Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company in New Zealand to obtain a licence to cultivate cannabis for research purposes. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain.

Company Details

Registered Office: 1 Commerce Place, Awapuni, Gisborne 4071

Postal Address: 1 Commerce Place, Awapuni, Gisborne 4071

Telephone: +64-6-390-6938

Facsimile: n/a

Website: www.ruabio.com

First Listed: 22/10/2020

Balance Date: 30 June

AGM: 12/10/2022

Directors and Executives

Tony Barclay

Independent Director

Panapa Ehau

Executive Director

Teresa Farac-Ciprian Independent Non-Executive Director

Brett Gamble

Non-Executive Director

Paul Naske

Chief Executive Officer

Anna Stove

Chair

Hamish White

Chief Financial Officer

Announcements

Title	Date	Type
Rua launches product into Czechia in major EU milestone	Mon, Sep 01 2025 09:31 am	MKTUPDTE
Preliminary Unaudited Annual Results	Mon, Sep 01 2025 08:30 am	FLLYR
Ongoing Disclosure Notice- Antony Barclay	Wed, Aug 20 2025 03:38 pm	SHINTR
Change of Registered Office and Address for Service	Wed, Aug 20 2025 03:12 pm	ADMIN
New Zealand grown products support Rua’s global strategy	Tue, Aug 19 2025 11:33 am	MKTUPDTE
Capital Change Notice	Mon, Aug 18 2025 08:30 am	SECISSUE
Capital Change Notice	Mon, Aug 18 2025 08:30 am	SECISSUE
2025 Annual Shareholders’ Meeting and Director Nominations	Fri, Aug 15 2025 09:41 am	GENERAL
Capital Change Notice	Thu, Aug 14 2025 12:19 pm	SECISSUE
Capital Change Notice	Tue, Aug 12 2025 10:13 am	SECISSUE

Major Holdings Announcements

Date	Name	No. Held	%	Current
22/12/22	Michael John Wilding	8,509,556	-	5.39
18/03/22	Hikurangi Enterprises Limited	8,132,620	-	5.43
17/03/22	Hikurangi Bioactives Limited Partne	4,000,000	12.58	2.67
22/10/20	Tailorspace Capital Limited, Tailor	11,129,375	-	7.95
22/10/20	Fang Group Investment Limited and F	23,584,939	-	16.85
22/10/20	Andrew Charles Williams	7,756,838	-	5.54

Director’s Interests Announcements

Date	Name	No. Held	%	Details	Other
31/05/23	Hamish White	80,895	-	-	-
17/05/23	Antony George Barclay	50,000	-	-	-
02/11/21	Paul Naske	159,872	-	-	-
02/11/21	Rob Mitchell	288,251	-	-	-
02/11/21	Panapa Ehau	474,224	-	-	-
02/11/21	Trevor Burt	958,002	-	-	-
22/10/20	Martin Smith	2,544,732	-	-	-
22/10/20	Brett Gamble	1,805,914	-	-	-
22/10/20	Anna Stove	763,896	-	-	-

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.

Last Updated: 06/06/2023